Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab

By afschroeder • October 23, 2025

Karapetians AG, Ayyagari T, Montana W. Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab. Cureus. 2025 Sep 21;17(9):e92816. doi: 10.7759/cureus.92816. PMID: 41127741; PMCID: PMC12538195.

Tags: ebv in hiv positive, ebv positive, ebv ptld, ebv-positive b-cell lymphoproliferative disease, ebv-positive lymphoproliferative disorder, ebv-positive mucocutaneous ulcer, epstein-barr virus (ebv), Hematology/Oncology, Kern, Publications, rituximab monotherapy, rituximab therapy

Related Posts

Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution study

LeVee A, Santos B, Wong M, Ruel N, Schmolze D, Kang I, Tsai K, Mortimer J, McArthur H. Predictors of pathologic complete response in early-stage[...]

Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD

Piotrowska Z, Goldberg SB, Goldman JW, de Langen AJ, Le X, Okamoto I, Riess JW, Yu HA, Nishino K, Novello S, Ponce S, Ambrose H,[...]

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer

Sayar E, Richards HM, Gulati R, Patel RA, Hanratty B, Lee HJ, Coleman I, Mustafi P, Ding CC, Chen WS, Quigley D, Setty M, Lang[...]